William Waterfield

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

The Lancet Oncology · 2010 · 979 citations

Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses?

Review · American Journal of Clinical Oncology · 2012 · 63 citations